Number of items: 1.
2002
Heidemann, E.,
Stoeger, H.,
Souchon, R.,
Hirschmann, W.-D.,
Bodenstein, H.,
Oberhoff, C.,
Fischer, J.T.,
Schulze, M.,
Clemens, M.,
Andreesen, R.,
Mahlke, M.,
König, M.,
Scharl, A.,
Fehnle, K. and
Kaufmann, M.
(2002)
Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.
Annals of Oncology 13 (11), pp. 1717-1729.
Fulltext not available.
This list was generated on Wed Jul 16 01:15:53 2025 CEST.